Physician profile
Brian Robert Sharp
NPI 1184672545
$3,042.48
in general payments reported to CMS, 2019-2025
11 companies · $882 in 2025
The $882 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2022: $433 · 2023: $615 · 2024: $955 · 2025: $882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,169 · Travel and Lodging: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,169.13 |
| Travel and Lodging | $282.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $996.09 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Abbvie INC. | $949.91 | 2022-2025 | |
| Curonix LLC | $297.51 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $256.11 | 2022-2024 | Painteq |
| Abbott Laboratories | $234.69 | 2021-2023 | Octrode |
| Collegium Pharmaceutical, INC. | $116.02 | 2021-2024 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $108.39 | 2021-2023 | Ztlido |
| Alnylam Pharmaceuticals INC. | $27.04 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.87 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.24 | 2024 | Relistor |
| Biodelivery Sciences International, INC. | $16.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.